JAK inhibitor, a new player for treatment-refractory microscopic colitis.
作者信息
Druez Anne, Travis Simon, Rahier Jean-François
机构信息
Department of Gastroenterology and Hepatology, CHU UCL Namur, Université catholique de Louvain, Yvoir, Belgium.
Kennedy Institute, Translational Gastroenterology Unit and Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
出版信息
Intest Res. 2023 Jul;21(3):411-412. doi: 10.5217/ir.2023.00030. Epub 2023 Jul 4.
Abstract
摘要
相似文献
1
JAK inhibitor, a new player for treatment-refractory microscopic colitis.
Intest Res. 2023 Jul;21(3):411-412. doi: 10.5217/ir.2023.00030. Epub 2023 Jul 4.
2
Microscopic colitis: A review of etiology, treatment and refractory disease.
World J Gastroenterol. 2015 Aug 7;21(29):8804-10. doi: 10.3748/wjg.v21.i29.8804.
3
Single-centre experience with anti-tumour necrosis factor treatment in budesonide-refractory microscopic colitis patients.
United European Gastroenterol J. 2019 Nov;7(9):1234-1240. doi: 10.1177/2050640619871750. Epub 2019 Aug 20.
4
Celiac Disease Is Associated with Microscopic Colitis in Refractory Cases in Adults: A Systematic Review and Meta-Analysis of Observational Studies.
Dig Dis Sci. 2022 Aug;67(8):3529-3542. doi: 10.1007/s10620-021-07232-7. Epub 2021 Aug 27.
5
Efficacy of anti-TNF therapies in refractory severe microscopic colitis.
J Crohns Colitis. 2011 Dec;5(6):612-8. doi: 10.1016/j.crohns.2011.05.001. Epub 2011 Jun 8.
6
Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease.
World J Gastroenterol. 2020 Jul 28;26(28):4055-4075. doi: 10.3748/wjg.v26.i28.4055.
7
Use of Ruxolitinib for the Simultaneous Treatment of Severe Refractory Ulcerative Colitis and Polycythemia Vera.
ACG Case Rep J. 2022 Jan 6;9(1):e00741. doi: 10.14309/crj.0000000000000741. eCollection 2022 Jan.
8
The role of upadacitinib in the treatment of ulcerative colitis.
Immunotherapy. 2023 Jul;15(10):713-727. doi: 10.2217/imt-2022-0299. Epub 2023 Apr 27.
9
Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis.
JCO Oncol Pract. 2020 Sep;16(9):e933-e942. doi: 10.1200/JOP.19.00672. Epub 2020 May 13.
10
[Microscopic colitis].
Ugeskr Laeger. 2002 Feb 11;164(7):884-7.
引用本文的文献
1
Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events.
Clin Endosc. 2024 Nov;57(6):725-734. doi: 10.5946/ce.2024.003. Epub 2024 Aug 29.
本文引用的文献
1
Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID.
J Crohns Colitis. 2022 Dec 5;16(12):1816-1824. doi: 10.1093/ecco-jcc/jjac089.
2
Course of Disease in Patients with Microscopic Colitis: A European Prospective Incident Cohort Study.
J Crohns Colitis. 2021 Jul 5;15(7):1174-1183. doi: 10.1093/ecco-jcc/jjab007.
3
Disease Activity Patterns, Mortality, and Colorectal Cancer Risk in Microscopic Colitis: A Danish Nationwide Cohort Study, 2001 to 2016.
J Crohns Colitis. 2021 Apr 6;15(4):594-602. doi: 10.1093/ecco-jcc/jjaa207.
4
The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.
J Crohns Colitis. 2017 Jul 1;11(7):885-893. doi: 10.1093/ecco-jcc/jjx003.
5
Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis.
Am J Gastroenterol. 2015 Feb;110(2):265-76; quiz 277. doi: 10.1038/ajg.2014.431. Epub 2015 Jan 27.
6
Microscopic colitis: clinical and pathologic perspectives.
Clin Gastroenterol Hepatol. 2015 Feb;13(2):228-36. doi: 10.1016/j.cgh.2013.12.026. Epub 2014 Jan 7.
7
Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile.
J Clin Pathol. 2007 Apr;60(4):382-7. doi: 10.1136/jcp.2005.036376. Epub 2006 Jun 14.
Zotero 插件